Accordingly, we were able to demonstrate that in leiomyoma cells in vitro treatment with nutlin-3, a small-molecule inhibitor of MDM2, activates the expression of canonical groups of genes associated with senescence and apoptosis downstream of p53 [9]. The gene discussed is MDM2; the disease is leiomyoma.